Back to Trades
Total Value
$20.2K
Filing Date
Nov 20, 2026
1 transactions
Trade Summary
On Nov 20, 2026, Taylor Andrew Lawrence, Chief Financial Officer, reported $20.2K of Orchestra BioMed Holdings, Inc. (OBIO) across 1 transactions. The filing covers Common Stock, par value $0.0001 per share and reflects balanced net activity of $0. Reported prices ranged from $6.58. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Orchestra BioMed Holdings, Inc.
- Ticker Symbol
- OBIO
- CIK
- 0001814114
Insider Information
- Role
- Chief Financial Officer
- Location
- NEW HOPE, PA
Filing Details
- Filing Date
- Nov 20, 2026
- Transaction Date
- Nov 20, 2026
- Accession Number
- 0001104659-26-130708
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 20, 2026 | Common Stock, par value $0.0001 per share | 3,076 | $6.58 | Tax Withholding | $20.2K |
Want live alerts when Taylor Andrew Lawrence trades again?
Download Insider Trades to track OBIO, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.